hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic
strategy and preventive measures are ill-defined. Ursodeoxycholic acid (UA) is well-
tolerated oral medication that has been associated with possible benefit as a prophylactic
agent. We sought to summarize and quantify the clinical effects of prophylactic UA in the
context of HSCT. We undertook a systematic review of studies addressing the use of UA as …